A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at Entheogyn and of counsel at Antithesis Law, joins Rebecca Nicholson, foundation director and wellness advisor at Prime Quadrant, to explore this evolving landscape with McGuireWoods partner and host Geoff Cockrell.
Matt discusses the tension between state and federal laws shaping access to psychedelics and controlled substances, while Rebecca contrasts the investment dynamics of cannabis versus psychedelics, emphasizing mental health over recreation. They examine specialized investor appetite, the medical community’s evolving response and the ancillary wellness modalities supporting comprehensive mental health transformation.